Study of TAVO103A in Healthy Volunteers

Clinical trial NCT05313152 · COMPLETED

Trial details

NCT number: NCT05313152
Sponsor: Tavotek Biotherapeutics
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Subjects

Start date: 2022-04-05
Primary completion: 2023-04-26
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.